A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure

Cytotherapy

Volumn 15, Issue 12, 2013, Pages 1571-1579

  Park, Chung Hwa ^a   Bae, Si Hyun ^a   Kim, Hee Yeon ^a   Kim, Ja Kyung ^b   Jung, Eun Sun ^a   Chun, Ho Jong ^a   Song, Myeong Jun ^a   Lee, Sung Eun ^a   Cho, Seok Goo ^a   Lee, Jong Wook ^a   Choi, Jong Young ^a   Yoon, Seung Kew ^a   Han, Nam Ik ^a   Lee, Young Sok ^a  

^a The Catholic University of Korea   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Autologous transplantation; Liver cirrhosis; Liver failure; Mesenchymal stromal cell

Indexed keywords

ALBUMIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; CYTOKERATIN 9; EPITHELIAL CELL ADHESION MOLECULE; PROPYLTHIOURACIL; STEM CELL FACTOR RECEPTOR;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CD34 DEPLETED BONE MARROW MONONUCLEAR CELL TRANSPLANTATION; CD34 SELECTION; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; HEPATIC ARTERY; HEPATITIS B; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER FAILURE; LIVER STIFFNESS; LIVER TRANSPLANTATION; LIVER WEIGHT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; THROMBOELASTOGRAPHY; TOXIC HEPATITIS; WILSON DISEASE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; RODENTIA;

AUTOLOGOUS TRANSPLANTATION; LIVER CIRRHOSIS; LIVER FAILURE; MESENCHYMAL STROMAL CELL;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HEPATIC ARTERY; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84887110147     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.05.013     Document Type: Article

References (30)

1. Kuo T.K., Hung S.P., Chuang C.H., Chen C.T., Shih Y.R., Fang S.C., et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008, 134:2111-2121. 21.e1-3.
2. Kisseleva T., Gigante E., Brenner D.A. Recent advances in liverstem cell therapy. Curr Opin Gastroenterol 2010, 26:395-402.
3. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
4. Brazelton T.R., Rossi F.M., Keshet G.I., Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000, 290:1775-1779.
5. Theise N.D., Nimmakayalu M., Gardner R., Illei P.B., Morgan G., Teperman L., et al. Liver from bone marrow in humans. Hepatology 2000, 32:11-16.
6. Mohamadnejad M., Namiri M., Bagheri M., Hashemi S.M., Ghanaati H., Zare Mehrjardi N., et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World JGastroenterol 2007, 13:3359-3363.
7. Oh S.H., Witek R.P., Bae S.H., Zheng D., Jung Y., Piscaglia A.C., et al. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 2007, 132:1077-1087.
8. Bae S.H., Choi J.Y., Yoon S.K., Oh I.H., Yoon K.H., Park S.T., et al. Thy1-positive bone marrow stem cells express liver-specific genes in vitro and can mature into hepatocytes in vivo. Hepatol Int 2008, 2:63-71.
9. Forbes S.J., Newsome P.N. New horizons for stem cell therapy in liver disease. JHepatol 2012, 56:496-499.
10. Stock P., Bruckner S., Ebensing S., Hempel M., Dollinger M.M., Christ B. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 2010, 5:617-627.
11. Sato Y., Araki H., Kato J., Nakamura K., Kawano Y., Kobune M., et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
12. Li T.Z., Kim J.H., Cho H.H., Lee H.S., Kim K.S., Lee S.W., et al. Therapeutic potential of bone-marrow-derived mesenchymal stem cells differentiated with growth-factor-free coculture method in liver-injured rats. Tissue Eng Part A 2010, 16:2649-2659.
13. Terai S., Ishikawa T., Omori K., Aoyama K., Marumoto Y., Urata Y., et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006, 24:2292-2298.
14. Lyra A.C., Soares M.B., da Silva L.F., Braga E.L., Oliveira S.A., Fortes M.F., et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur JGastroenterol Hepatol 2010, 22:33-42.
15. Lyra A.C., Soares M.B., da Silva L.F., Fortes M.F., Silva A.G., Mota A.C., et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007, 13:1067-1073.
16. Pai M., Spalding D., Xi F., Habib N. Autologous bone marrow stem cells in the treatment of chronic liver disease. Int JHepatol 2012, 2012:307165.
17. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEngl J Med 2006, 355:1210-1221.
18. Snyder E.Y., Daley G.Q., Goodell M. Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system. JNeurosci Res 2004, 76:157-168.
19. Eve D.J., Fillmore R.W., Borlongan C.V., Sanberg P.R. Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation. Cell Transplant 2010, 19:1493-1509.
20. Kim J.K., Park Y.N., Kim J.S., Park M.S., Paik Y.H., Seok J.Y., et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 2010, 19:1237-1246.
21. Ezzat T.M., Dhar D.K., Newsome P.N., Malago M., Olde Damink S.W. Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?. Liver Int 2011, 31:773-784.
22. El-Ansary M., Abdel-Aziz I., Mogawer S., Abdel-Hamid S., Hammam O., Teaema S., et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev 2012, 8:972-981.
23. Peng L., Xie D.Y., Lin B.L., Liu J., Zhu H.P., Xie C., et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011, 54:820-828.
24. Rice H.E., O'Keefe G.E., Helton W.S., Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997, 132:880-884. discussion 884-5.
25. Chan S.C., Lo C.M., Chok K.S., Sharr W.W., Cheung T.T., Tsang S.H., et al. Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation. Hepatobiliary Pancreat Dis Int 2011, 10:649-656.
26. Eipel C., Abshagen K., Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010, 16:6046-6057.
27. Gauthier T.P., Wasan H.S., Muhammad A., Owen D.R., Leen E.L. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound. JUltrasound Med 2011, 30:379-385.
28. Alison M.R., Islam S., Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. JPathol 2009, 217:282-298.
29. Sakaida I., Terai S., Yamamoto N., Aoyama K., Ishikawa T., Nishina H., et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004, 40:1304-1311.
30. Saito T., Okumoto K., Haga H., Nishise Y., Ishii R., Sato C., et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 2011, 20:1503-1510.